22 augustus 2009: Bron: 1: Eur J Cancer. 2008 Nov;44(17):2608-14. Epub 2008 Sep 14

Magnesium naast chemokuren met cisplatin en paclitaxel bij eierstokkanker beschermt significant beter de nieren dan chemo zonder magnesium. Dat blijkt uit een in 3 groepen gerandomiseerde dubbelblinde placebo gecontroleerde fase II studie bij 81 eierstokkankerpatienten met plaveiselcarcinoom.

1: Eur J Cancer. 2008 Nov;44(17):2608-14. Epub 2008 Sep 14.

Renal protection with magnesium subcarbonate and magnesium sulphate in patients with epithelial ovarian cancer after cisplatin and paclitaxel chemotherapy: a randomised phase II study.
Bodnar L, Wcislo G, Gasowska-Bodnar A, Synowiec A, Szarlej-Wcis³o K, Szczylik C.
Department of Oncology, Military Institute of The Health Services, Warsaw, Poland. lubo@esculap.pl
BACKGROUND: The aim of this study was to examine the effect of magnesium supplementation on nephrotoxicity accompanying standard cisplatin-based chemotherapy in patients with epithelial ovarian cancer (EOC).
PATIENTS AND METHODS: A double-blind, placebo-controlled, randomised study was conducted in which study arm magnesium sulphate (5 g) was administered before each course of standard chemotherapy with paclitaxel (135 mg/m(2)/24 h) plus cisplatin (75 mg/m(2)) every 3 weeks in patients with EOC. Magnesium subcarbonate (500 mg), three times per day orally, was administered during the treatment intervals. The control arm was administered a placebo instead of both magnesium salts. Magnesium serum levels (sMg) and GFR markers: serum levels of creatinine (sCr), Cockroft-Gault (ClCG) and Modification Diet of Renal Disease (MDRD) formulae were recorded before each cycle, and 3 weeks after the sixth course.
RESULTS: 41 EOC patients were randomised and 40 were eligible. sMg varied significantly between the supplemented and placebo groups (p<0.0001). The control group showed a significantly greater decrease of GFR assessed by: sCr (p=0.0069), ClCG (p=0.0077) and MDRD (p=0.032) formulae compared with the magnesium supplemented group.
CONCLUSIONS: These results demonstrate the nephroprotective effect of magnesium supplementation during chemotherapy with cisplatin.


Plaats een reactie ...

Reageer op "Magnesium naast chemokuren met cisplatin en paclitaxel bij eierstokkanker beschermt significant beter de nieren dan chemo zonder magnesium, aldus gerandomiseerde en placebo gecontroleerde dubbelblinde fase 2 studie."

Gerelateerde artikelen

Gerelateerde artikelen

Studiepublicaties van niet-toxische >> Psychologische interventie >> Kytogeen dieet bij patienten >> Dr. Felperlaan geeft adviezen >> Magnesium naast chemokuren >> Een vegetarisch vezelrijk >> Twee patienten met eierstokkanker >> Flavonoiden lijken beschermend >> Genisteine aglycone kan eierstokkanker >> Groene thee vergroot kansen >>